JOURNAL OF AUTOIMMUNITY

Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.

Journal Title

J AUTOIMMUN

ISSN / eISSN

0896-8411 / 1095-9157

Aims and Scope

The Journal of Autoimmunity is a parent journal of the Journal of Translational Autoimmunity. The Journal of Autoimmunity publishes papers related to the diverse aspects of autoimmunity: the mechanism of self-recognition, regulation of autoimmune responses, experimental autoimmune diseases, diagnostic autoantibody tests, and the epidemiology, pathophysiology, and treatment of autoimmune diseases. Special, but not exclusive, attention will be given to papers dealing with genetic, molecular biology, and cellular aspects of the discipline.

Research Areas Include:

• Underlying mechanisms of autoimmunity
• Immunologic
• Molecular
• Cellular
• Genetic
• Virologic

Areas of Clinical Interest:

• Rheumatology
• Dermatology
• Endocrinology
• Nephrology
• Haematology
• Immunopharmacology

Subject Area

IMMUNOLOGY

CiteScore

24.90

View Trend

CiteScore Ranking

Category	Quartile	Rank
Medicine - Immunology and Allergy	Q1	#9/211
Medicine - Immunology	Q1	#10/217

Web of Science Core Collection

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

Category (Journal Citation Reports 2023)	Quartile
IMMUNOLOGY - SCIE	Q1

H-index

101

Country/Area of Publication

ENGLAND

Publisher

Academic Press Inc.

Publication Frequency

Bimonthly

Year Publication Started

1988

Annual Article Volume

111

Open Access

Contact

ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD, 24-28 OVAL RD, LONDON, ENGLAND, NW1 7DX

Popular journals in the same field
Recent articles

Lung transplantation in pulmonary sarcoidosis: (2023) Jin Sun Kim, Rohit Gupta

Pulmonary sarcoidosis: A comprehensive review: Past to present: (2023) John A. Belperio, Michael C. Fishbein, Fereidoun Abtin, Jessica Channick, Shailesh A. Balasubramanian, Joseph P. Lynch III

Genetic predisposition to sarcoidosis: (2023) Shu-Yi Liao, Tasha Fingerlin, Lisa Maier

Circulating T cells in sarcoidosis have an aberrantly activated phenotype that correlates with disease outcome: (2023) Jelle R. Miedema, Lieke J. de Jong, Denise van Uden, Ingrid M. Bergen, Mirjam Kool, Caroline E. Broos, Vivienne Kahlmann, Marlies S. Wijsenbeek, Rudi...

Rapamycin nanoparticles increase the therapeutic window of engineered interleukin-2 and drive expansion of antigen-specific regulatory T cells for protection against autoimmune disease: (2023) Takashi Kei Kishimoto, Max Fournier, Alicia Michaud, Gina Rizzo, Christopher Roy, Teresa Capela, Natasha Nukolova, Ning Li, Liam Doyle, Fen-ni Fu, Der...

Cognition following chimeric antigen receptor T-cell therapy: A systematic review: (2023) Christina Kazzi, Valeriya Kuznetsova, Pakeeran Siriratnam, Sarah Griffith, Shu Wong, Constantine S. Tam, Rubina Alpitsis, Andrew Spencer, Terence J. O...

Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients: (2023) Christa Lichtensteiger, Maximilian Koblischke, Fiamma Berner, Ann-Kristin Jochum, Tobias Sinnberg, Beatrice Balciunaite, Mette-Triin Purde, Vincent Wa...

Autoimmune pancreatitis type 2 (idiopathic duct-centric pancreatitis): A comprehensive review: (2023) Yang Li, Hanyi Song, Xiangzhen Meng, Runzhuo Li, Patrick S.C. Leung, M. Eric Gershwin, Shucheng Zhang, Siyu Sun, Junmin Song

Quality of life in sarcoidosis: (2023) Catharina C. Moor, Ogugua Ndili Obi, Vivienne Kahlmann, Katharina Buschulte, Marlies S. Wijsenbeek

Sarcoidosis and its relation to other immune-mediated diseases: Epidemiological insights: (2023) Elizabeth V. Arkema, Marios Rossides, Yvette C. Cozier

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now